In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma.
暂无分享,去创建一个
M. Rugge | M. Fassan | A. Alberti | M. Greene | A. Buda | G. Sturniolo | M I Greene | G. Hatem | M Fassan | M Rugge | G. Battaglia | A Alberti | S Realdon | E Dassie | L Dall'Olmo | G Hatem | A Buda | D Arcidiacono | G Diamantis | H Zhang | G C Sturniolo | G Battaglia | S. Realdon | D. Arcidiacono | L. Dall'Olmo | G. Diamantis | E. Dassie | H. Zhang | L. Dall’Olmo
[1] B. Liu,et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. , 1997, Carcinogenesis.
[2] R. Cestari,et al. TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma , 2010, Histopathology.
[3] Martin Goetz,et al. Molecular in vivo imaging of gastric cancer in a human-murine xenograft model: targeting epidermal growth factor receptor. , 2012, Gastrointestinal endoscopy.
[4] Katherine S. Garman,et al. Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[5] M. Rugge,et al. Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. , 2012, Human pathology.
[6] K. Danenberg,et al. Validation of a rodent model of Barrett’s esophagus using quantitative gene expression profiling , 2009, Surgical Endoscopy.
[7] R. Langer,et al. Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation , 2011, Modern Pathology.
[8] Kenneth K Wang,et al. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.
[9] G. Sauter,et al. HER-2 amplification is highly homogenous in gastric cancer. , 2010, Human pathology.
[10] O. Ogunwobi,et al. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study , 2007, BMC Cancer.
[11] M. Rugge,et al. Early HER2 dysregulation in gastric and oesophageal carcinogenesis , 2012, Histopathology.
[12] M. Moasser. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis , 2007, Oncogene.
[13] M. Rugge,et al. CDX2 hox gene product in a rat model of esophageal cancer , 2009, Journal of experimental & clinical cancer research : CR.
[14] J. T. Jørgensen. Targeted HER2 Treatment in Advanced Gastric Cancer , 2010, Oncology.
[15] H. Sugihara,et al. Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model. , 2003, Scandinavian journal of gastroenterology.
[16] R. Kiesslich,et al. Confocal endomicroscopy: in vivo diagnosis of neoplastic lesions of the gastrointestinal tract. , 2008, Anticancer research.
[17] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[18] T. Lange,et al. Trastuzumab has anti-metastatic and anti-angiogenic activity in a spontaneous metastasis xenograft model of esophageal adenocarcinoma. , 2011, Cancer Letters.
[19] E. Cho,et al. HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer , 2006, Digestive Diseases and Sciences.
[20] L. Pecciarini,et al. HER2 Testing in Gastric Cancer , 2011, Advances in anatomic pathology.
[21] R. Langer,et al. Successful evaluation of a new animal model using mice for esophageal adenocarcinoma , 2010, Langenbeck's Archives of Surgery.
[22] A. Polglase,et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. , 2004, Gastroenterology.
[23] P. Rigotti,et al. Heterotopic cardiac xenotransplantation in rodents: Report of a refined technique in a hamster‐to‐rat model , 2005, Microsurgery.
[24] R. Conigliaro,et al. Advances in Endoscopic Visualization of Barrett's Esophagus: The Role of Confocal Laser Endomicroscopy , 2012, Gastroenterology research and practice.
[25] M. J. van de Vijver,et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study , 2008, Histopathology.
[26] R. Cestari,et al. Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett's esophagus: a translational approach. , 2008, Minerva gastroenterologica e dietologica.
[27] Thomas D. Wang,et al. Molecular imaging in gastrointestinal endoscopy. , 2010, Gastroenterology.
[28] Yoon-Koo Kang,et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial , 2010, The Lancet.
[29] P. Pfau,et al. Probe-Based Confocal Laser Endomicroscopy to Guide Real-Time Endoscopic Therapy in Barrett's Esophagus with Dysplasia , 2012, Case Reports in Gastroenterology.
[30] A. Gavin,et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. , 2011, Journal of the National Cancer Institute.
[31] A. Thrift,et al. Current Status and Future Perspectives on the Etiology of Esophageal Adenocarcinoma , 2011, Front. Oncol..
[32] D. Hicks,et al. HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options , 2012, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[33] F. Schmitt,et al. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients , 2009, British Journal of Cancer.
[34] T. Hattori,et al. Reflux of duodenal or gastro‐duodenal contents induces esophageal carcinoma in rats , 1996, International journal of cancer.
[35] D. Hicks,et al. HER2 Testing in Gastric and Gastroesophageal Junction Cancers: A New Therapeutic Target and Diagnostic Challenge , 2011, Applied immunohistochemistry & molecular morphology : AIMM.
[36] J. Crawford,et al. Endoscopic evaluation of esophago-gastro-jejunostomy in rat model of Barrett's esophagus. , 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[37] A. Jimeno,et al. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[38] A. Bhardwaj,et al. Barrett's Esophagus: Emerging Knowledge and Management Strategies , 2012, Pathology research international.
[39] R. Kiesslich,et al. In vivo molecular imaging of epidermal growth factor receptor in patients with colorectal neoplasia using confocal laser endomicroscopy. , 2013, Cancer letters.